Partner Headlines - BIIB

  1. Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst

    Investors Business Daily
  2. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily
  3. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily
  4. Trump Twitter Hangover Keeps Biotech Stocks Down

    TalkMarkets
  5. Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, ...

    Investors Business Daily
  6. Forward Pharma settles the case with Biogen

    TalkMarkets
  7. Biogen Pays Forward Pharma $1.25 Billion To Settle Tecfidera ...

    Investors Business Daily
  8. Trump Says Drugmakers 'Getting Away With Murder', Cites F-35, ...

    Investors Business Daily
  9. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit ...

    Investors Business Daily
  10. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit ...

    Investors Business Daily
  11. Investors Siphon Biogen, Ionis Gains After Spinal Disease Drug's ...

    Investors Business Daily
  12. Texas Instruments A Buy; Biogen, 21st Century Fox PTs Hiked

    Investors Business Daily
  13. AveXis Slides after Biogen, Ionis SMA Drug Approval

    TalkMarkets
  14. Ionis Pharma Eyes Sustainable Profitability After FDA Approval

    Investors Business Daily
  15. Nasdaq Clears 5,500 To Fresh All-Time High; Apple Vies For Breakout

    Investors Business Daily
  16. Stock Futures Mixed, Quiet; FDA Approval Lifts Biogen, Ionis

    Investors Business Daily
  17. Exclusive Q&A: Ionis CEO Sees Watershed 2017 On 'Rapid' Drug ...

    Investors Business Daily
  18. Two Lessons From My Biogen Trade

    TalkMarkets
  19. Biogen Likely To Trim EPS View On Hemophilia Spinoff, Floundering ...

    Investors Business Daily
  20. Biogen Likely To Trim EPS View On Hemophilia Spinoff, Floundering ...

    Investors Business Daily
  21. Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug

    TalkMarkets
  22. Gilead Buying Alexion Tops Piper's Potential Events In 2017

    TalkMarkets
  23. Biogen CEO Change Raises Analyst Questions On Takeover Potential ...

    TalkMarkets
  24. Biogen Takeout Still Possible After Internal Promotion For CEO: ...

    Investors Business Daily
  25. New Biogen CEO Reduces Potential For Takeout, Says Jefferies ...

    TalkMarkets
  26. Biogen Names Insider New CEO After Five-Month Search, Stock Falls

    Investors Business Daily
  27. Does The Symbolism Of Dow 20K Affect Technical Analysis?

    TalkMarkets
  28. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets
  29. Biogen Underplays Promising Alzheimer's Data On Seizure Worries

    Investors Business Daily
  30. Stocks Up Again; Apple Strengthens, Reclaims 50-Day Line

    Investors Business Daily
  31. Stocks Up, Biogen Rebounds; Why Apple Is Flexing Strength Again

    Investors Business Daily
  32. Biogen Alzheimer's Drug Shows More Promise; Lilly Data Tonight

    Investors Business Daily
  33. Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key

    Investors Business Daily
  34. Trump Vow On Drug Prices Hammers Drug Stocks, But Key Indexes ...

    Investors Business Daily
  35. Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink

    TalkMarkets
  36. Dow Jones Industrial Average Hits New Record In Afternoon Trading ...

    TalkMarkets
  37. Paid To Wait? Eli Lilly Crashes To 2 Year Lows, Erases 6 Years ...

    TalkMarkets
  38. Morgan Stanley Expects Big Reversal Today In Biogen Shares

    TalkMarkets
  39. Magic Recipe Movers - The Trump Effect

    TalkMarkets
  40. On The Fly: Top stock stories for Monday

    TalkMarkets
  41. Biogen Rises After Muscular Disorder Drug Data, Piper Upgrade ...

    TalkMarkets
  42. Morning Call For Monday, Nov. 7

    TalkMarkets
  43. Biogen Upgraded To Overweight From Neutral At Piper Jaffray

    TalkMarkets
  44. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets
  45. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  46. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex ...

    TalkMarkets
  47. 5 Stocks To Watch Before The Market Opens Tomorrow (October 26, ...

    TalkMarkets
  48. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets
  49. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron ...

    TalkMarkets
  50. Fed Minutes Show Conflicted Central Bank

    TalkMarkets
  51. Biotech Stock Roundup: Alnylam Slumps On Revusiran Update, TESARO ...

    TalkMarkets
  52. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets
  53. Earnings ESP

    TalkMarkets
  54. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets
  55. Stock Indexes Mostly Flat; Time Warner Rises; Tesla Earnings ...

    Investors Business Daily
  56. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For ...

    Investors Business Daily
  57. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily
  58. QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To ...

    Investors Business Daily
  59. Nasdaq Ends Near Record High; Oil Stocks Sink Dow, S&P 500

    Investors Business Daily
  60. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily
  61. Indexes Mixed As Oil Stocks Tumble; Alphabet Near High

    Investors Business Daily
  62. Nasdaq Poised To Surpass 5200; Other Indexes Lag On Oil Stock ...

    Investors Business Daily
  63. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch ...

    Investors Business Daily
  64. Ionis, Biogen Score Surprise Win Against Childhood Spinal Disease

    Investors Business Daily
  65. Stocks Open Narrowly Mixed; SolarCity Falls On Tesla Deal

    Investors Business Daily
  66. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or ...

    Investors Business Daily
  67. SPY ETF Posts Fourth Weekly Gain As Chip And Biotech Giants Surge

    Investors Business Daily
  68. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, ...

    Investors Business Daily
  69. Stocks Down At Midday; Biogen Leads Biotech Rebound

    Investors Business Daily
  70. Biogen CEO Quits Amid M&A Speculation; Company Hikes Outlook

    Investors Business Daily
  71. Investing Action Plan: Starbucks, AT&T, Chipotle, Biogen, Visa, ...

    Investors Business Daily
  72. John Paulson Bulks Up Health Care Bet

    GuruFocus
  73. Gilead, Johnson & Johnson or Roche?

    GuruFocus
  74. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist ...

    GuruFocus
  75. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  76. Former Leaders Show Up On New Low List; D.R. Horton Sinks Again

    IBD
  77. Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth

    IBD
  78. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD
  79. Maybe Some Good News For A Big Biotech ETF

    Benzinga
  80. Sobi to present new interim ASPIRE data at EAHAD congress suggesting ...

    Benzinga
  81. Earnings Recap For January 27

    Benzinga
  82. Apple and Boeing Earnings, Plus Oil Drag, Combine to Dent Stocks

    Benzinga
  83. Biogen's Stock Pops Following Better-Than-Expected Q4 Results

    Benzinga
  84. 10 Stocks Moving In Wednesday's Pre-Market Session

    Benzinga
  85. Earnings Scheduled For January 27, 2016

    Benzinga
  86. Big Earnings Expectations For Big Biotech

    Benzinga
  87. Biogen Ticks Up Following EU Marketing Authorization Of Benepali

    Benzinga
  88. Biogen, Samsung JV Announces Etanercept Biosimilar Referencing ...

    Benzinga
  89. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD
  90. This Week Is Paramount For Biotech Stocks

    Benzinga
  91. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus
  92. Jean Hynes Finds Her Pot of Gold

    GuruFocus
  93. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga
  94. Not All Of Clinton's Policies Are Bad For Pharmaceuticals

    Benzinga
  95. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD
  96. Early Global News: Virtual Reality Market Getting Really Big, ...

    Benzinga
  97. Sanofi chips at Biogen share

    IBD
  98. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  99. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  100. Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia ...

    Benzinga
Trading Center